MYCN and neuroblastoma: Moreover, the depletion of ATP and NAD+ levels were observed across all tested neuroblastoma cell lines (SK-N-BE(2)C, NGP, and SH-SY5Y) when targeting LINE-1 or when targeting MYCN in MYCN-amplified neuroblastoma cell lines (SK-N-BE(2)C, and NGP; Supplementary Fig. 16).